Founders Capital Management
Source: SEC Form 13F · as of Mar 2026Founders Capital Management holds 25 biotech & pharma companies tracked by BioSniper, totaling $22.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
25
Total value held
$22.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 46,292 | $11.3M |
| ABBVAbbVie Inc. | 24,695 | $5.4M |
| MRKMerck & Co., Inc. | 36,752 | $4.4M |
| PFEPFIZER INC | 12,564 | $353K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 550 | $149K |
| AMGNAMGEN INC | 409 | $144K |
| BMYBRISTOL MYERS SQUIBB CO | 1,500 | $91K |
| GILDGILEAD SCIENCES, INC. | 512 | $71K |
| PMPhilip Morris International Inc | 379 | $63K |
| GMABGenmab A/S | 1,400 | $38K |
| GEHCGE HealthCare Technologies Inc. | 499 | $36K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 75 | $33K |
| GMOptec International, Inc. | 378 | $28K |
| LCTXLineage Cell Therapeutics, Inc. | 16,000 | $25K |
| NATRNATURES SUNSHINE PRODUCTS INC | 1,000 | $24K |
| OCULOCULAR THERAPEUTIX, INC | 2,500 | $21K |
| LNTHLantheus Holdings, Inc. | 250 | $19K |
| ARRYARRAY BIOPHARMA INC | 2,500 | $18K |
| CPRXCATALYST PHARMACEUTICALS, INC. | 600 | $15K |
| OGIORGANIGRAM GLOBAL INC. | 11,000 | $15K |
| OGNOrganon & Co. | 2,000 | $12K |
| VKTXViking Therapeutics, Inc. | 300 | $10K |
| LSTALISATA THERAPEUTICS, INC. | 1,667 | $8K |
| SGMOSANGAMO THERAPEUTICS, INC | 6,000 | $1K |
| JAZZJazz Pharmaceuticals plc | 4 | $756 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.